Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?

12 Feb 2024

Abstract excerpt

Cancer immunotherapies have been widely hailed as a breakthrough for cancer treatment in the last decade, epitomized by the unprecedented results observed with checkpoint blockade. Even so, only a minority of patients currently achieve durable remissions. In general, responsive patients appear to have either a high number of tumor neoantigens, a preexisting immune cell infiltrate in the tumor microenvironment, or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cancer Research and Treatments
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38346140
DOI: 10.1080/1040841x.2024.2311653

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?PMID 38346140Read ↗

Roles of microbiota in response to cancer immunotherapySemantic proximity Read ↗

Unlocking The Potential and Myth of Personalized Vaccines, CRISPR-CAS9, and Bacteriotherapy, as Therapeutic Options for CancerSemantic proximity Read ↗

Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota compositionSemantic proximity Read ↗

Coley`s Toxin to first Approved Therapeutic Vaccine - a Brief Historical Account in the Progression of Immunobiology Based Cancer TreatmentSemantic proximity Read ↗

A Mimicry-Based Strategy Between Human and Commensal Antigens for the Development of a New Family of Immune Therapies for CancerSemantic proximity Read ↗

<i>Enterococcus</i> peptidoglycan remodeling promotes immune checkpoint inhibitor therapySemantic proximity Read ↗

Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implicationsSemantic proximity Read ↗

Tumour neoantigen mimicry by microbial species in cancer immunotherapy.Semantic proximity Read ↗

In Situ Synthesis of an Immune-Checkpoint Blocker from Engineered Bacteria Elicits a Potent Antitumor ResponseSemantic proximity Read ↗

Microbial cancer immunotherapy reprograms hematopoiesis to enhance anti-tumor immunitySemantic proximity Read ↗

Contribution of the Immune Response to Phage TherapySemantic proximity Read ↗

Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.